10 patients with resistant or relapsed acute leukemia ( 9 aml , 1 all ) were treated with idarubicin ( 4-demethoxydaunorubicin ) in combination with cytosine arabinoside +/- etoposide .
C0023467
aml
C0020789
4-demethoxydaunorubicin